Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial.
about
New Antituberculosis Drugs: From Clinical Trial to Programmatic UseManagement of multidrug-resistant TB: novel treatments and their expansion to low resource settingsEmerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?Medical Management of Drug-Resistant TuberculosisNew developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanidProgrammatic Management of Drug-Resistant Tuberculosis: An Updated Research AgendaThe best of respiratory infections from the 2015 European Respiratory Society International CongressWorld Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update.Update in Mycobacterium tuberculosis lung disease 2014.Efficacy of ultra-short course chemotherapy for new smear positive drug susceptible pulmonary tuberculosis: study protocol of a multicenter randomized controlled clinical trial.Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in GeorgiaThe need to accelerate access to new drugs for multidrug-resistant tuberculosis.Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines.Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan.Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in GermanyBurden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis.The Challenge of Pulmonary Nontuberculous Mycobacterial Infection.Drug-Resistant Tuberculosis: Challenges and Progress.Economic evaluation of a shortened standardised treatment regimen of antituberculosis drugs for patients with multidrug-resistant tuberculosis (STREAM): study protocol.Safety and availability of clofazimine in the treatment of multidrug and extensively drug-resistant tuberculosis: analysis of published guidance and meta-analysis of cohort studies.Bedaquiline for the treatment of drug-resistant tuberculosis.A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TB.The paradigm shift to end tuberculosis. Are we ready to assume the changes?Mechanisms of action and therapeutic efficacies of the lipophilic antimycobacterial agents clofazimine and bedaquiline.The changing landscape in drug resistant-tuberculosis: an analysis of recent advances.Scenario Analysis for Programmatic Tuberculosis Control in Western Province, Papua New Guinea.Current therapies for the treatment of multidrug-resistant tuberculosis in children in India.Adverse Effects and Choice between the Injectable Agents Amikacin and Capreomycin in Multidrug-Resistant Tuberculosis.Estimated generic prices for novel treatments for drug-resistant tuberculosis.[Drug-resistant tuberculosis. Epidemiology, diagnostics and therapy].Treating tuberculosis with high doses of anti-TB drugs: mechanisms and outcomes.Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen.Issues in design and interpretation of MDR-TB clinical trials: report of the first Global MDR-TB Clinical Trials Landscape Meeting.Target regimen profiles for treatment of tuberculosis: a WHO document.Challenges of using new and repurposed drugs for the treatment of multidrug-resistant tuberculosis in children.Shorter & cheaper regimen to treat multidrug-resistant tuberculosis: A new hope.Of Testing and Treatment: Implications of Implementing New Regimens for Multidrug-Resistant Tuberculosis.
P2860
Q26741138-3768A92B-25CD-4080-A089-4936ED01154BQ26765394-6FDA8C57-CDEC-4132-8C61-A397132F97C8Q26771997-DA76679D-C171-484C-AB4D-D8CFBA73E9BEQ26801601-E32D6801-2407-4B62-A7F3-06CB8D46D3DEQ27003210-6FD95E81-B99F-4398-A0D3-C5DF92ECC048Q28552438-FDDC49B8-63BA-487E-BFF2-FD21241207CDQ28598393-4C9CD4DD-FB9D-4D11-9024-6E27EB9F1172Q30377488-E3381203-5F22-40ED-A5B9-D661ACA397BCQ33735642-37B1A114-0F9B-44D9-9D82-838F581D0D54Q33810454-84BE2B03-0C92-4439-BEC7-A2F46AE3665CQ33896434-BC03A9B4-2396-477B-96C1-C831058F8CB1Q35815071-7B0E1DDC-FE58-4BE8-98DF-5D2E4613E086Q36094215-01653FBC-8657-4BDF-963A-3EE8EB0CD233Q36195588-581D5DFE-F37C-471F-8031-A0940282878EQ36300175-25476096-D265-4744-870C-105995FE6356Q36386227-26D4E739-9CF0-468D-9D9D-3F4CD4A5537DQ36567746-1FEBF2E9-EAB6-4432-84B2-446F0E758353Q36924283-88F5F5A1-0D28-437B-918B-750A39B71804Q37356114-7D075D28-994C-4001-99F8-0127C55686FBQ37516784-B4DC05EE-90AC-4EBF-AF2C-5A6EB263338CQ38386950-E46C1A02-1DC7-41C8-A640-618F4B87EDA6Q38582633-68A01D09-647E-4E2E-8FF6-81FD1C2FA3C1Q38676708-37EB93BA-FC34-48E8-BE5D-58D35CB1B851Q38995175-5D504080-CC37-4FB9-B9A8-2D3EA370AC27Q39262652-16890622-6BC9-45B5-BEC1-B36654DCCB1CQ39751186-BD2A39A1-B86E-474B-94BC-3A0AD090F966Q40067743-94F3422F-38A9-4520-B496-0E7BA8CE126AQ40139987-E91F445D-470B-48B1-B8AB-3D31D2EDAE26Q40377338-DFD7F205-3ED6-4596-9DCA-ABBD04C13C37Q40959612-CEDEA4F5-0626-427D-8A49-43B222FEC790Q42281128-E7C706B2-59B6-4C3A-B074-529F7031FA1BQ43200280-AFA17B95-C4EE-449B-8405-8A493671BBC6Q45922051-058F38C0-BB40-4A8A-93B0-DE37CDDF0689Q46813086-FF78E877-0DBD-4328-A33E-EE1EBBDD6C11Q47244908-235FD19D-818E-47E2-AAB3-60B9D7145BDBQ49513327-55F82E44-3C00-41CC-BA01-AADE941FB51BQ52648707-96DBA994-EB8C-4A62-81C9-66D55E822B25
P2860
Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Evaluation of a standardized t ...... a randomized controlled trial.
@ast
Evaluation of a standardized t ...... a randomized controlled trial.
@en
Evaluation of a standardized t ...... ti-drug-resistant tuberculosis
@nl
type
label
Evaluation of a standardized t ...... a randomized controlled trial.
@ast
Evaluation of a standardized t ...... a randomized controlled trial.
@en
Evaluation of a standardized t ...... ti-drug-resistant tuberculosis
@nl
prefLabel
Evaluation of a standardized t ...... a randomized controlled trial.
@ast
Evaluation of a standardized t ...... a randomized controlled trial.
@en
Evaluation of a standardized t ...... ti-drug-resistant tuberculosis
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Evaluation of a standardized t ...... a randomized controlled trial
@en
P2093
Armand Van Deun
Chen-Yuan Chiang
Gabriela Torrea
Sarah K Meredith
P2860
P2888
P356
10.1186/1745-6215-15-353
P577
2014-09-09T00:00:00Z
P5875
P6179
1008451801